US FDA declines to approve Viatris's injection for multiple sclerosis The U.S. FDA has declined to approve Viatris and Mapi Pharma's once-a-month injection for treating relapsing forms of debilitating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback